Date Filed | Type | Description |
08/25/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,522 shares
@ $23.22, valued at
$58.6k
|
|
08/23/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,478 shares
@ $22.6, valued at
$56k
|
|
08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,768 shares
@ $23.79, valued at
$65.9k
|
|
08/14/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,857 shares
@ $24.15, valued at
$69k
|
|
08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/08/2023 |
4
| Ho Carole (Director) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
05/12/2023 |
4
| Ho Carole (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
02/14/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 818 shares
@ $29.8, valued at
$24.4k
Sold 2,548 shares
@ $30.1, valued at
$76.7k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 1,459 shares
@ $28.48, valued at
$41.6k
|
|
01/09/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,636 shares
@ $28.44, valued at
$75k
Sold 1,451 shares
@ $28.67, valued at
$41.6k
|
|
01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/02/2022 |
4
| Ho Carole (Director) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
08/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/15/2022 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,918 shares
@ $34.71, valued at
$101.3k
|
|
02/11/2022 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 1,423 shares
@ $37.0987, valued at
$52.8k
|
|
01/07/2022 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,845 shares
@ $44.78, valued at
$127.4k
|
|
01/05/2022 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Granted 31,000 shares
@ $0 Granted 93,000 options to buy
@ $47.27, valued at
$4.4M
|
|
12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|